Cargando…

Metastatic breast cancer: Endocrine therapy landscape reshaped

Endocrine therapy (ET) of hormone receptor (HR)-positive and human epidermal growth factor receptor 2-(HER2)-negative metastatic breast cancer (MBC) historically focused on estrogen deprivation and antagonism. The identification of several intracellular pathways promoting resistance to antiestrogen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salkeni, Mohamad Adham, Hall, Samantha June
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655644/ https://www.ncbi.nlm.nih.gov/pubmed/29119080 http://dx.doi.org/10.4103/ajm.AJM_20_17

Ejemplares similares

Neu Perspectives, Therapies, and Challenges for Metastatic HER2-Positive Breast Cancer
por: Salkeni, Mohamad Adham, et al.
Publicado: (2021)

Updates in endocrine therapy for metastatic breast cancer
por: Manohar, Poorni M., et al.
Publicado: (2022)

Prognostic factors in breast cancer patients evaluated by positron-emission tomography/computed tomography before neoadjuvant chemotherapy
por: Farrugia, Mark K., et al.
Publicado: (2018)

Reshaping the research landscape in Brazil
por: Crestana, Gustavo Schiavone, et al.
Publicado: (2023)

Breakthrough Technologies Reshape the Ewing Sarcoma Molecular Landscape
por: Salguero-Aranda, Carmen, et al.
Publicado: (2020)

Endocrine therapy combined with targeted therapy in hormone receptor-positive metastatic breast cancer
por: Bian, Li, et al.
Publicado: (2020)

Nip the HPV encoded evil in the cancer bud: HPV reshapes TRAILs and signaling landscapes
por: Halim, Talha Abdul, et al.
Publicado: (2013)

Epigenetic factor competition reshapes the EMT landscape
por: Al-Radhawi, M. Ali, et al.
Publicado: (2022)

How I treat endocrine-dependent metastatic breast cancer
por: Gombos, A., et al.
Publicado: (2023)

RUNX1 reshapes the epigenetic landscape at the onset of haematopoiesis
por: Lichtinger, Monika, et al.
Publicado: (2012)

DNA methylation disruption reshapes the hematopoietic differentiation landscape
por: Izzo, Franco, et al.
Publicado: (2020)

Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
por: D’Souza, Anishka, et al.
Publicado: (2018)

Endocrine Therapy-Based Strategies for Metastatic Breast Cancer with Different Endocrine Sensitivity Statuses: A Systematic Review and Network Meta-Analysis
por: Wang, Jiani, et al.
Publicado: (2022)

Hormonal treatment combined with targeted therapies in endocrine-responsive and HER2-positive metastatic breast cancer
por: Montagna, Emilia, et al.
Publicado: (2019)

Status of adjuvant endocrine therapy for breast cancer
por: Schiavon, Gaia, et al.
Publicado: (2014)

The immunomodulatory effects of endocrine therapy in breast cancer
por: Huang, Huanhuan, et al.
Publicado: (2021)

Significance of the Genomic Landscape of a De Novo Endocrine-Resistant Metastatic Hormone Receptor–Positive Breast Cancer
por: Sarma, Maithreyi, et al.
Publicado: (2020)

Chemotherapy Modulates Endocrine Therapy-Related Resistance Mutations in Metastatic Breast Cancer
por: Zhou, Dabo, et al.
Publicado: (2019)

Amplifying recombination genome-wide and reshaping crossover landscapes in Brassicas
por: Pelé, Alexandre, et al.
Publicado: (2017)

"Resurrection of clinical efficacy" after resistance to endocrine therapy in metastatic breast cancer
por: Agrawal, Amit, et al.
Publicado: (2006)

Novel Strategies to Improve the Endocrine Therapy of Breast Cancer
por: Castrellon, Aurelio Bartolome
Publicado: (2017)

Clinical activity of fulvestrant in metastatic breast cancer previously treated with endocrine therapy and/or chemotherapy
por: Heo, Mi Hwa, et al.
Publicado: (2019)

Iron Reshapes the Gut Microbiome and Host Metabolism
por: Botta, Amy, et al.
Publicado: (2021)

Pharmacological chaperone reshapes the energy landscape for folding and aggregation of the prion protein
por: Gupta, Amar Nath, et al.
Publicado: (2016)

Lysine Acetylation Reshapes the Downstream Signaling Landscape of Vav1 in Lymphocytes
por: Rodríguez-Fdez, Sonia, et al.
Publicado: (2020)

How directed evolution reshapes energy landscapes in enzymes to boost catalysis
por: Otten, Renee, et al.
Publicado: (2020)

Deficiency of ribosomal proteins reshapes the transcriptional and translational landscape in human cells
por: Luan, Yizhao, et al.
Publicado: (2022)

Association of Endocrine Therapy for HR+/ERBB2+ Metastatic Breast Cancer With Survival Outcomes
por: Carausu, Marcela, et al.
Publicado: (2022)

Endocrinology and hormone therapy in breast cancer: Endocrine therapy in premenopausal women
por: Pritchard, Kathleen
Publicado: (2005)

MMP9 modulates the metastatic cascade and immune landscape for breast cancer anti-metastatic therapy
por: Owyong, Mark, et al.
Publicado: (2019)

Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers
por: El-Botty, Rania, et al.
Publicado: (2023)

Pharmacogenomics of endocrine therapy in breast cancer
por: Ingle, James N
Publicado: (2013)

Endocrine Therapy for Breast Cancer: A Model of Hormonal Manipulation
por: Johnston, Simon J., et al.
Publicado: (2018)

Neoadjuvant Endocrine Therapy in Breast Cancer Management: State of the Art
por: Lerebours, Florence, et al.
Publicado: (2021)

The Present and Future of Neoadjuvant Endocrine Therapy for Breast Cancer Treatment
por: Martí, Covadonga, et al.
Publicado: (2021)

Current Strategies of Endocrine Therapy in Elderly Patients with Breast Cancer
por: Lee, Suk-young, et al.
Publicado: (2018)

Reshaping the phonon energy landscape of nanocrystals inside a terahertz plasmonic nanocavity
por: Jin, Xin, et al.
Publicado: (2018)

Metformin Reshapes the Methylation Profile in Breast and Colorectal Cancer Cells
por: Sabit, Hussein, et al.
Publicado: (2018)

A paraneoplastic manifestation of metastatic breast cancer responding to endocrine therapy: a case report
por: Wood, Joanna P, et al.
Publicado: (2008)

RETRACTION: Challenges of Combined Everolimus/Endocrine Therapy in Hormone Receptor-Positive Metastatic Breast Cancer
por: Porta, Camillo
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_h6f3pmavt7fb2lplgcu3r9npoe